Chromatin-remodeling factor BAZ1A/ACF1 targets UV damage sites in an MLL1-dependent manner to facilitate nucleotide excision repair. 2022

Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
Department of Molecular Biology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-Ku, Hamamatsu, Shizuoka 431-3192, Japan.

Ultraviolet (UV) light irradiation generates pyrimidine dimers on DNA, such as cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts. Such dimers distort the high-order DNA structure and prevent transcription and replication. The nucleotide excision repair (NER) system contributes to resolving this type of DNA lesion. There are two pathways that recognize pyrimidine dimers. One acts on transcribed strands of DNA (transcription-coupled NER), and the other acts on the whole genome (global genome-NER; GG-NER). In the latter case, DNA damage-binding protein 2 (DDB2) senses pyrimidine dimers with several histone modification enzymes. We previously reported that histone acetyltransferase binding to ORC1 (HBO1) interacts with DDB2 and facilitates recruitment of the imitation switch chromatin remodeler at UV-irradiated sites via an unknown methyltransferase. Here, we found that the phosphorylated histone methyltransferase mixed lineage leukemia 1 (MLL1) was maintained at UV-irradiated sites in an HBO1-dependent manner. Furthermore, MLL1 catalyzed histone H3K4 methylation and recruited the chromatin remodeler bromodomain adjacent to zinc finger domain 1A (BAZ1A)/ATP-utilizing chromatin assembly and remodeling factor 1 (ACF1). Depletion of MLL1 suppressed BAZ1A accumulation at UV-irradiated sites and inhibited the removal of CPDs. These data indicate that the DDB2-HBO1-MLL1 axis is essential for the recruitment of BAZ1A to facilitate GG-NER.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011740 Pyrimidine Dimers Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION. Cyclobutane Pyrimidine Dimer,Cyclobutane-Pyrimidine Dimer,Cytosine-Thymine Dimer,Pyrimidine Dimer,Thymine Dimer,Thymine Dimers,Cyclobutane-Pyrimidine Dimers,Cytosine-Thymine Dimers,Thymine-Cyclobutane Dimer,Thymine-Thymine Cyclobutane Dimer,Cyclobutane Dimer, Thymine-Thymine,Cyclobutane Dimers, Thymine-Thymine,Cyclobutane Pyrimidine Dimers,Cytosine Thymine Dimer,Cytosine Thymine Dimers,Pyrimidine Dimer, Cyclobutane,Pyrimidine Dimers, Cyclobutane,Thymine Cyclobutane Dimer,Thymine Thymine Cyclobutane Dimer,Thymine-Cyclobutane Dimers,Thymine-Thymine Cyclobutane Dimers
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D002868 Chromosomal Proteins, Non-Histone Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. Non-Histone Chromosomal Proteins,Chromosomal Proteins, Non Histone,Chromosomal Proteins, Nonhistone,Non-Histone Chromosomal Phosphoproteins,Chromosomal Phosphoproteins, Non-Histone,Non Histone Chromosomal Phosphoproteins,Non Histone Chromosomal Proteins,Nonhistone Chromosomal Proteins,Proteins, Non-Histone Chromosomal
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
December 2009, Cell cycle (Georgetown, Tex.),
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
May 2002, European journal of biochemistry,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
April 2001, The EMBO journal,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
June 2010, The Journal of biological chemistry,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
January 2012, International journal of molecular sciences,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
September 2016, Human mutation,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
October 2010, Proceedings of the National Academy of Sciences of the United States of America,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
March 2017, DNA repair,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
February 2003, The EMBO journal,
Takafumi Koyauchi, and Hiroyuki Niida, and Akira Motegi, and Satoshi Sakai, and Chiharu Uchida, and Tatsuya Ohhata, and Kenta Iijima, and Akihiko Yokoyama, and Takafumi Suda, and Masatoshi Kitagawa
May 2009, Methods (San Diego, Calif.),
Copied contents to your clipboard!